文献速递银屑病与炎症性皮肤病

靛玉红浓度对青黛软膏治疗银屑病疗效比较:随机双盲剂量对照试验

Comparison of indirubin concentrations in indigo naturalis ointment for psoriasis treatment: a randomized, double-blind, dosage-controlled trial.
PubMed 文献 · Br J Dermatol · 2017-12-14

该随机双盲试验将慢性斑块状银屑病患者(BSA<20%)随机分配至含200、100、50或10 μg g-1靛玉红的Lindioil软膏组,每日两次外用8周,随后12周安全/扩展期。主要终点为PASI评分平均百分比变化及PASI 75/90比例。

要点

  • 200 μg g-1组PASI 75和PASI 90应答率分别为57%和30%,均显著高于其他浓度组。
  • 20周评估期间未报告严重治疗相关不良事件。

核心结论

  • 200 μg g-1靛玉红在Lindioil软膏中是所研究的最有效浓度,且安全性良好。

研究设计与样本

  • 随机双盲剂量对照试验,纳入慢性斑块状银屑病>1年且BSA<20%的成人患者,随机分配至200、100、50或10 μg g-1靛玉红软膏组,每日两次外用8周,随后12周安全/扩展期。

主要发现

  • 20周评估期间未报告严重治疗相关不良事件。

关键数值与推荐

  • 主要终点为第8周PASI评分平均百分比变化及PASI 75和PASI 90比例。

临床怎么用

  • 对于BSA<20%的慢性斑块状银屑病成人患者,可考虑外用含200 μg g-1靛玉红的Lindioil软膏,每日两次。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Indigo naturalis and its refined formulation, Lindioil, are effective in treating psoriatic symptoms topically. Indirubin is the active ingredient in indigo naturalis. OBJECTIVES: To determine the efficacy and safety of different concentrations of indirubin in Lindioil ointment for treating psoriasis. METHODS: In this randomized, double-blind trial, adult patients presenting with chronic plaque psoriasis for > 1 year and with < 20% of the body surface area (BSA) affected were randomized to apply Lindioil ointment containing 200, 100, 50 or 10 μg g-1 of indirubin twice daily for 8 weeks followed by an additional 12-week safety/extension period. The primary end point was the mean percentage change in Psoriasis Area and Severity Index (PASI) score along with the proportion of participants achieving 75% and 90% reductions in PASI scores (PASI 75 and PASI 90, respectively) from baseline to week 8. RESULTS: The results from week 8 revealed that the 200 μg g-1 group had the greatest reduction in PASI score [69·2%, 95% confidence interval (CI) 55·5-82·8], followed by the 100 μg g-1 group (63·1%, 95% CI 52·8-73·5), the 10 μg g-1 group (53·4%, 95% CI 42·8-64·0) and the 50 μg g-1 group (50·3%, 95% CI 37·4-63·2), with a between-group comparison of P = 0·0445. The group with the highest proportion of the patients achieving PASI 75 (57%, P = 0·0474) and PASI 90 (30%, P = 0·0098) was the 200 μg g-1 group. No severe treatment-related adverse events were reported during the 20-week evaluation. CONCLUSIONS: An amount of 200 μg g-1 of indirubin in Lindioil ointment is the most effective concentration studied so far for treating psoriasis topically, and is safe.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Lin YK, See LC, Huang YH, et al. Comparison of indirubin concentrations in indigo naturalis ointment for psoriasis treatment: a randomized, double-blind, dosage-controlled trial. Br J Dermatol. 2017. PMID: 28815560. doi:10.1111/bjd.15894

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。